Hamburg - Start of a new trial site

On the 23rd June, 2026, the University hospital Hamburg-Eppendorf became officially another active trial site of the STOP-PKD Study. The team of  Dr. Fabian Braun  cares for patients with a wide range of nephrological issues, including those affected by autosomal dominant polycystic kidney disease (ADPKD).

Interested patients can now make an appointment at the trial site in Hamburg to obtain detailed information about the trail and potential participation.

Phone: 

Email: